HomeEVGN • NASDAQ
add
Evogene Ltd
Previous close
$1.60
Day range
$1.52 - $1.67
Year range
$1.44 - $10.40
Market cap
8.19M USD
Avg Volume
556.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 1.80M | -52.32% |
Operating expense | 8.17M | 9.83% |
Net income | -7.63M | -91.52% |
Net profit margin | -424.83 | -301.69% |
Earnings per share | -1.31 | -63.75% |
EBITDA | -6.83M | -93.87% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.95M | -46.40% |
Total assets | 40.11M | -30.53% |
Total liabilities | 27.88M | 27.39% |
Total equity | 12.24M | — |
Shares outstanding | 6.79M | — |
Price to book | -2.50 | — |
Return on assets | -45.97% | — |
Return on capital | -110.69% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -7.63M | -91.52% |
Cash from operations | -4.93M | -14.15% |
Cash from investing | — | — |
Cash from financing | 4.73M | -39.30% |
Net change in cash | 1.83M | -74.18% |
Free cash flow | 757.88K | 124.92% |
About
Evogene is a computational biology company based in Israel. Evogene Ltd. has developed a unique computational predictive biology "CPB" platform, which leverages big data with advanced algorithms such as machine learning and other artificial intelligence, while adding a deep understanding of biology and advanced biological technologies. Evogene is using its proprietary CPB platform to computationally design and develop next-generation life-science products based upon three core components: microbes, small molecules, and genetic elements.
Evogene's computational platform allows it to substantially increase the probability of successful life-science product development, increase the efficiency and reduce the toxicity of its life-science products while reducing time and cost to development. Its strategic partners include BASF, Bayer, Corteva, ICL Group Ltd. as well as various academic and medical institutions. Wikipedia
CEO
Founded
2002
Website
Employees
142